356.4K
Downloads
250
Episodes
The Cardiovascular CME podcast is a new educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
Episodes
4 days ago
4 days ago
Exploring New Frontiers in Rhythm Monitoring Technology
Guest: Suraj Kapa, M.D.
Host: Anthony H. Kashou, M.D.
After listening to this podcast, the learners will be able to confidently identify areas of advancement in cardiac rhythm monitoring. Additionally, listeners will learn specific areas of future research around technology to support the future of cardiac rhythm monitoring.
Topics Discussed:
- What is new in technology to advance rhythm monitoring?
- What role is AI playing in rhythm monitoring?
- What are potential risks associated with these technological advances?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
Updates from the 2024 ESC and AHA Scientific Statements on Cardiac Sarcoidosis
Guest: Leslie T. Cooper Jr., M.D.
Host: Kyle W. Klarich, M.D.
Cardiac sarcoidosis is a systemic, chronic inflammatory disorder characterized by non-caseating, epithelioid cell granulomas that may involve many tissues and organs. The Heart Rhythm Society criteria for diagnosis of cardiac sarcoidosis require a biopsy-proven diagnosis of extra-cardiac sarcoidosis. If extra-cardiac sarcoidosis is confirmed, CS is highly probable when there is evidence of the following: (a) rhythm abnormalities in either ECG or Holter monitoring such as advanced AVB (Mobitz type II second-degree or third-degree AVB), sustained VT, and (b) LV dysfunction on echocardiography or CMR (LVEF <40%) and/or compatible pattern on advanced imaging modalities (cardiac PET, CMR). EMB, sometimes with electrogram guidance to increase diagnostic yield, remains useful in indeterminant cases, including isolated cardiac involvement or suspected genetic etiology. Multidisciplinary teams consisting of respiratory physicians, rheumatologists, and cardiologists with expertise in sarcoidosis as well as other relevant subspecialties such as advanced cardiac imaging specialists (CMR and nuclear medicine) and electrophysiologists are needed to integrate immunosuppression with arrhythmia and heart failure management.
Topics Discussed:
- What percentage of patients with cardiac sarcoidosis have lung or thoracic lymph node involvement?
- Which of the following are associated with greater risk of heart failure or ventricular arrhythmias in definite or probable cardiac sarcoidosis:
- Which of the following medications may be added to guideline directed treatments for the initial management of acute and symptomatic cardiac sarcoidosis?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Mar 11, 2025
Tuesday Mar 11, 2025
New RNA Therapies for Treatment of ASCVD, Prevention, and Dyslipidemia
Guest: R. Scott Wright, M.D.
Host: Stephen L. Kopecky, M.D.
RNA therapies are growing in number as targeted treatments for dyslipidemia including LDL-c, Lp(a) and Triglycerides. The podcast will explore the science behind these therapies, the evidence for safety and how clinicians can utilize them in their practices.
Topics Discussed:
- What are the new RNA therapies available or soon to be available?
- How are RNA based therapies being used?
- How do they compare to the COVID-19 vaccine?
- What is their effectiveness and side effect profile?
- Are there side effects or concerns?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Mar 04, 2025
Tuesday Mar 04, 2025
Myocarditis: What’s New in 2025
Guest: Leslie T. Cooper Jr., M.D.
Host: Kyle W. Klarich, M.D.
After this episode of Mayo Clinic’s cardiovascular podcast series “Interviews With the Experts,” the listener will be able to identify the novel 2024 ACC Expert Care Decision Pathway (ECDP) 4-stage classifications of myocarditis. Hear today’s expert discuss pivotal tests in the diagnosis of myocarditis, such as cardiac magnetic resonance (CMR) imaging and endomyocardial biopsy (EMB) are considered. Finally, learn more about the indications for genetic testing for myocarditis in your patients.
Topics Discussed:
- What percentage of adult patients with myocarditis presenting as heart failure with reduced ejection fraction or ventricular arrhythmias have a pathogenic or likely pathogenic cardiomyopathic gene variant?
- Which of the following are criteria to consider endomyocardial biopsy in the setting of acute myocarditis?
- Identify Stage B myocarditis based on clinical presentation and testing.
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Feb 25, 2025
Tuesday Feb 25, 2025
Post-Cardiac Ablation Atrial Arrhythmia Monitoring
Guest: Suraj Kapa, M.D.
Host: Anthony H. Kashou, M.D.
In this episode of the segment "ECG Making Waves," the listener will learn to identify the right monitoring approach for a given patient’s arrhythmia considerations around ablation. They will also learn how to list specific considerations when reviewing and interpreting post-ablation arrhythmia ECGs.
Topics Discussed:
- What specific aspects of the ECG and ECG monitoring are important to look for after cardiac ablation?
- How do you approach rhythm monitoring discussions with your patients after ablation?
- What are potential benefits and pitfalls of different monitoring approaches for atrial arrhythmias after ablation?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Feb 18, 2025
Tuesday Feb 18, 2025
Lipid Drugs: Part 2
Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N
Host: Stephen L. Kopecky, M.D.
In Part 2, we will explore potential side effects and barriers to prescribing these medications, considering various patient factors. If you missed Part 1 last week, we encourage you to listen to it first, as this episode serves as a continuation and conclusion of that discussion.
Topics Discussed:
- Side effects of these newer non-statin drugs
- Barriers to prescribing those drugs
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Feb 11, 2025
Tuesday Feb 11, 2025
Lipid Drugs: Part 1
Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N
Host: Stephen L. Kopecky, M.D.
In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available treatment options, alternative dosing schedules, and strategies for introducing newer medications. Stay tuned for Part 2, where they will examine the side effects of these newer drugs and barriers to prescribing them.
Topics Discussed:
- What are the non-stain medications available and how are they different from statins?
- How do you decide which medication to use when patients are statin intolerant?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Feb 04, 2025
Tuesday Feb 04, 2025
Heart Lung Transplantation
Guest: Richard C. Daly, M.D.
Guest: Philip J. Spencer, M.D.
Host: Kyle Klarich, M.D.
Heart lung transplantation is the transplant of the combined heart-lung organ bloc from a donor into a recipient who has end-stage disease of both the heart and the lungs. This is often necessary because the disease in 1 of the organs (the heart or the lungs) caused the disease in the other organ system. For example, pulmonary hypertension might cause gradual but irreversible right ventricular failure in the heart. The prognosis after heart-lung transplantation is similar to patients who receive isolated lung transplantation.
Topics Discussed:
- Heart-lung transplantation and why it is unique.?
- Types of diseases that would require heart-lung transplantation.
- Prognosis after heart-lung transplantation compared to heart transplant and lung transplant survival.
- Immunologic advantages to block heart-lung transplantation.
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Jan 28, 2025
Tuesday Jan 28, 2025
Mayo Clinic's Experience with Cardioneural Ablation
Guest: Guru Kowlgi, M.B.B.S.
Host: Anthony H. Kashou, MD
After listening to this podcast, the learners will develop a fundamental understanding of cardioneural ablation, as well as which patients should be referred for the procedure. Additionally, they will get a sense of the outcomes of the cardioneural ablation program at Mayo Clinic.
Topics Discussed:
- Give us a quick refresher of what cardioneural ablation is, and which patient is appropriate to be referred for cardioneural ablation?
- What is the history of cardioneural ablation? When did you start the cardioneural ablation program at Mayo Clinic?
- How many cases have you done? What are the outcomes in terms of syncope-free survival and are there any complications?
- What differentiates Mayo Clinic from other centers performing this procedure?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.
Tuesday Jan 21, 2025
Tuesday Jan 21, 2025
Aortic Valve Prosthesis Selection
Guest: Kimberly Holst, M.D.
Host: Sharonne Hayes, M.D.
In this podcast we will learn to identify patient specific factors to be considered during evaluation for aortic valve replacement including patient specific anatomy, comorbidities, and lifelong management of aortic valve disease. Learners will learn to identify advantages to mechanical and biologic prostheses for management of aortic valve disease and identify areas of developing technology and treatment options for aortic valve disease.
Topics Discussed:
- What are the main factors to consider when evaluating a patient for aortic valve replacement?
- What patient specific factors that may make a patient less suitable for transcatheter aortic valve replacement (TAVR)?
- What are the advantages of each mechanical and biologic prostheses in treatment of aortic valve disease?
- What new technologies are available for management of aortic valve disease?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.